DHHS-CGH: Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America Under PEPFAR
Deadline: 19 February 2020
The Department of Health and Human Services, Centres for Disease Control is seeking applications for its Scaling Up High-Impact HIV Prevention, Testing and Treatment Models in Central America under the President’s Emergency Plan for AIDS Relief (PEPFAR).
Goals
- Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission;
- Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs), and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART);
- Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring, and HIV screening for blood safety;
- Developing, validating, and/or evaluating public health programs to inform, improve, and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB, and opportunistic infections.
Program Outcomes
Short-Term Outcomes
- Increased access to HIV testing among key populations and partners of index cases
- Increased access to PreP among individuals at highest risk of HIV infection
- Increased availability and analysis of HIV rapid recency results
- Improved effective linkage to care and treatment among individuals newly diagnosed with HIV
- Increased early treatment initiation, retention and adherence among PLHIV
- Improved access to viral load testing among PLHIV
- Improved monitoring of HIV drug resistance
- Increased adoption of PEPFAR-supported strategies within national guidelines and manuals
Intermediate Outcomes
- Increased HIV case finding among key populations and partners of index cases
- Reduced late HIV diagnosis among key populations and partners of index cases
- Sustained negative HIV test results among individuals on PreP
- Improved public health response to clusters of active HIV transmission
- Improved treatment initiation rates among key populations and partners of index cases
- Improved viral load suppression among PLHIV
- Increased coverage of PEPFAR-supported strategies at the national level
Long-Term Outcomes
- Increased country ownership of PEPFAR-supported initiatives
Funding Information
- Approximate Total Fiscal Year Funding: $5,000,000
Eligibility Criteria
- Government Organizations:
- Political subdivisions of States (in consultation with States)
- Non-government Organizations:
- Alaska Native health corporations
- Tribal epidemiology centers
- Urban Indian health organizations
- Nonprofit with 501C3 IRS status (other than institution of higher education)
- Nonprofit without 501C3 IRS status (other than institution of higher education)
- Research institutions (that will perform activities deemed as non-research)
- Colleges and Universities
- Community-based organizations
- Faith-based organizations (FBOs)
- For-profit organizations (other than small business)
- Hospitals
- Small, minority, and women-owned businesses
- All Other
For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=319479